Zobrazeno 1 - 10
of 140
pro vyhledávání: '"antilichamen"'
In context of an increasing interest in immunotherapeutic treatments, the work described in this thesis expands the current knowledge of several potential antibody-based therapeutic approaches. A new development is the use of bispecific antibodies (B
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=narcis______::a061548634b6cd4341d39e8867718786
https://dspace.library.uu.nl/handle/1874/427766
https://dspace.library.uu.nl/handle/1874/427766
In context of an increasing interest in immunotherapeutic treatments, the work described in this thesis expands the current knowledge of several potential antibody-based therapeutic approaches. A new development is the use of bispecific antibodies (B
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dris___00893::ef9a94dcfadcdd24c00231e6f934334f
https://hdl.handle.net/1874/427766
https://hdl.handle.net/1874/427766
Autor:
Robbers, Lisa
The first weeks of life are a critical period in the development of the newborn ruminant. Newborn ruminants are quite vulnerable since both on a farm as well as in nature they are exposed to various pathogens. Because they have a placental type that
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_______101::cddd12903f6cd55e31f41910c009bd26
https://dspace.library.uu.nl/handle/1874/424023
https://dspace.library.uu.nl/handle/1874/424023
The first weeks of life are a critical period in the development of the newborn ruminant. Newborn ruminants are quite vulnerable since both on a farm as well as in nature they are exposed to various pathogens. Because they have a placental type that
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dris___00893::1f3ef0a6e0b3900bce12b7e2f3731b09
https://doi.org/10.33540/1545
https://doi.org/10.33540/1545
Autor:
Hoek, Max, Afd Biomol.Mass Spect. and Proteomics, Biomolecular Mass Spectrometry and Proteomics
Chapters 2, 3, and 4 describe and demonstrate the intact immunoglobulin protein profiling technique, which was employed to assess the serum of milk antibody repertoire in individual donors. Chapter 2 introduces the method for analysis of the serum Ig
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=narcis______::8d5419347f0db2e65da5d5252f328953
https://dspace.library.uu.nl/handle/1874/423780
https://dspace.library.uu.nl/handle/1874/423780
Chapters 2, 3, and 4 describe and demonstrate the intact immunoglobulin protein profiling technique, which was employed to assess the serum of milk antibody repertoire in individual donors. Chapter 2 introduces the method for analysis of the serum Ig
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dris___00893::8019dffdbfeb488ea51ade72ac45d0d1
https://doi.org/10.33540/1535
https://doi.org/10.33540/1535
Autor:
Hoek, Max
Chapters 2, 3, and 4 describe and demonstrate the intact immunoglobulin protein profiling technique, which was employed to assess the serum of milk antibody repertoire in individual donors. Chapter 2 introduces the method for analysis of the serum Ig
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_______101::a85a630c66235f393f8e50407f492dc9
https://dspace.library.uu.nl/handle/1874/423780
https://dspace.library.uu.nl/handle/1874/423780
Autor:
van der Horst, Hilma Jacoba
Publikováno v:
van der Horst, H J 2021, ' Moving cancer therapy forward: Engineered antibodies for the treatment of B-cell malignancies ', Dr., Vrije Universiteit Amsterdam, Amsterdam .
van der Horst, H J 2021, ' Moving cancer therapy forward: Engineered antibodies for the treatment of B-cell malignancies ', Doctor of Philosophy, Vrije Universiteit Amsterdam, Amsterdam . < https://hdl.handle.net/1871.1/d4a63979-9505-41f8-a7c1-c4e2053f7187 >
van der Horst, H J 2021, ' Moving cancer therapy forward: Engineered antibodies for the treatment of B-cell malignancies ', Doctor of Philosophy, Vrije Universiteit Amsterdam, Amsterdam . < https://hdl.handle.net/1871.1/d4a63979-9505-41f8-a7c1-c4e2053f7187 >
B-cell malignancies define a subset of hematological cancers, including the B-cell proliferative disorders B-cell chronic lymphocytic leukemia (B-CLL) and B-cell non Hodgkin lymphoma’s (B-NHL) and the plasma cell proliferative disorder multiple mye
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::20c437eacdf3da9a25a15fc167cbaf78
https://research.vumc.nl/en/publications/68eb874c-09da-480c-b8f3-ecf01f058644
https://research.vumc.nl/en/publications/68eb874c-09da-480c-b8f3-ecf01f058644
B-cell malignancies define a subset of hematological cancers, including the B-cell proliferative disorders B-cell chronic lymphocytic leukemia (B-CLL) and B-cell non Hodgkin lymphoma’s (B-NHL) and the plasma cell proliferative disorder multiple mye
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______4612::fdb62fe9b375e31259f4ae7f86b216c0
https://research.vu.nl/en/publications/d4a63979-9505-41f8-a7c1-c4e2053f7187
https://research.vu.nl/en/publications/d4a63979-9505-41f8-a7c1-c4e2053f7187
Autor:
Patricia van den Hoogen
Heart failure (HF) is one of the most common cardiovascular diseases, affecting approximately 26 million people worldwide and is characterized by adverse cardiac remodeling and a reduced ability of the heart to maintain cardiac output. One of the key
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9b574592353650b923520c94c85fe833
https://doi.org/10.33540/141
https://doi.org/10.33540/141